跳至主要内容
临床试验/KCT0000664
KCT0000664终止未知

A prospective randomized study to compare incidence of acute rejection and graft/patient survival between prednisolone ( or methylprednisolone) withdrawal 3 months after transplant and maintaining with Tacrobell and Myfortic in low-risk kidney transplant recipient selected by immune monitoring method

Samsung Medical Center0 个研究点目标入组 236 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
终止
入组人数
236

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 65(Year)(—)
性别
All

入选标准

  • 1.Primary live donor transplant patients aged 18 to 65 years
  • 2.Either female patients of child bearing potential with negative pregnancy test and agreed to practice birth control while receiving or male patients
  • 3.Patients must be willing and able to provide written informed consent.

排除标准

  • 1.Deceased donor transplant patients
  • 2.Patients who have HLA identical live donor
  • 3.Patients who have current PRA > 50%.
  • 4.Patients who are recipients of or schedulled for non-renal transplants.
  • 5.Patients with known positive results of the following serological tests: HIV-1 Ab, HbsAg, or anti-HCV ab.
  • 6.Patients with evidence of active infection.
  • 7.Patients with a history of malignancies.
  • 8.Patients who have congestive heart failure (Ejection fraction < 35%)

研究者

相似试验